Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Pixium Vision

Pixium Vision announces the rejection of the sale plan (plan de cession) by the Court and the conversion of the receivership proceedings into liquidation proceedings
From Pixium Vision
Via GlobeNewswire
Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings to January 31, 2024
From Pixium Vision
Via GlobeNewswire
Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings
From Pixium Vision
Via GlobeNewswire
Decision concerning the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings scheduled for January 16, 2024
From Pixium Vision
Via GlobeNewswire
Commercial Court hearing to examine the takeover offer scheduled for December 18, 2023
From Pixium Vision
Via GlobeNewswire
Update on the receivership proceedings: submission of a takeover offer to the court-appointed administrators
From Pixium Vision
Via GlobeNewswire
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD
From Pixium Vision
Via GlobeNewswire
Pixium Vision announces the conversion of the safeguard proceedings into receivership
From Pixium Vision
Via GlobeNewswire
Pixium Vision announces its financial results for H1 2023 and provides update
From Pixium Vision
Via GlobeNewswire
Pixium Vision announces the launch of a process to find buyers
From Pixium Vision
Via GlobeNewswire
Pixium Vision announces the opening of safeguard proceedings
From Pixium Vision
Via GlobeNewswire
Pixium Vision announces the completion of the reverse stock split of its shares on the basis of 1 new share for 50 existing shares and the start of trading of the shares resulting after the completion of the reverse split as of Sep 21, 2023
From Pixium Vision
Via GlobeNewswire
Pixium Vision announces the implementation of a bridge financing with Bpifrance and Sofinnova and a reverse stock split on the basis of 1 new share for 50 existing shares
From Pixium Vision
Via GlobeNewswire
Pixium Vision announces the agreement to extend the maturity date of the outstanding notes associated with the terminated ESGO financing facility
From Pixium Vision
Via GlobeNewswire
Results of the Annual General Shareholder Meeting as of June 13, 2023
From Pixium Vision
Via GlobeNewswire
Pixium Vision announces receipt of € 1.8 million from the French Government as Research Tax Credit
From Pixium Vision
Via GlobeNewswire
Annual Meeting of Shareholders June 13, 2023 / Availability of preparatory documents
From Pixium Vision
Via GlobeNewswire
Pixium Vision convenes its Annual Meeting of Shareholders on June 13, 2023
From Pixium Vision
Via GlobeNewswire
Pixium Vision announces the availability of its annual report for the financial year 2022
From Pixium Vision
Via GlobeNewswire
Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31, 2023
From Pixium Vision
Via GlobeNewswire
Communication following the announcement of FDA Breakthrough Device Designation for the Prima System in Dry AMD
From Pixium Vision
Via GlobeNewswire
Pixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMD
From Pixium Vision
Via GlobeNewswire
Reduction of share capital due to losses by reduction of nominal value: number of shares unchanged
From Pixium Vision
Via GlobeNewswire
Results of Extraordinary Shareholders Meeting held on March 8, 2023
From Pixium Vision
Via GlobeNewswire
Extraordinary Shareholder Meeting of March 8, 2023: Notice of publication of the preparatory documents
From Pixium Vision
Via GlobeNewswire
Second convening of the Extraordinary Shareholder Meeting on March 8, 2023
From Pixium Vision
Via GlobeNewswire
Pixium Vision announces its cash position at 31 December 2022 and provides an update on its activities
From Pixium Vision
Via GlobeNewswire
Pixium Vision announces termination of convertible note financing agreement with US-based healthcare investor ESGO
From Pixium Vision
Via GlobeNewswire
Extraordinary General Meeting of February 15, 2023: Notice of publication of the preparatory documents
From Pixium Vision
Via GlobeNewswire
Pixium Vision convenes an Extraordinary General Meeting of Shareholders on February 15, 2023
From Pixium Vision
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.